{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:24:19Z","timestamp":1790688259029,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"am","delay-in-days":296,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.diabet.2022.101409","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T21:57:20Z","timestamp":1668549440000},"page":"101409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes"],"prefix":"10.1016","volume":"49","author":[{"given":"Guillaume","family":"Treiber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Guilleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriane","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania","family":"Flaus\u2013Furmaniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Couret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Mellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Le-Moullec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Doray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"J\u00e9ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Maiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhoopendrasing","family":"Domun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Cogne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Meilhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Meikle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7427-0108","authenticated-orcid":false,"given":"Estelle","family":"Nob\u00e9court","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2022.101409_bib0001","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.semcdb.2013.12.015","article-title":"Nuclear envelope-related lipodystrophies","volume":"29","author":"Gu\u00e9nantin","year":"2014","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.diabet.2022.101409_bib0002","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabet.2022.101409_bib0003","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/db19-0447","article-title":"Clinical and molecular prevalence of lipodystrophy in an unascertained large clinical care cohort","volume":"69","author":"Gonzaga-Jauregui","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2022.101409_bib0004","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2022.101409_bib0005","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142245","article-title":"Severe insulin resistance syndromes","volume":"131","author":"Angelidi","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.diabet.2022.101409_bib0006","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1172\/JCI129190","article-title":"What lipodystrophies teach us about the metabolic syndrome","volume":"129","author":"Mann","year":"2019","journal-title":"J Clin Investig"},{"key":"10.1016\/j.diabet.2022.101409_bib0007","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/ATVBAHA.113.301933","article-title":"Lipodystrophy-Linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction","volume":"33","author":"Bidault","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabet.2022.101409_bib0008","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-21-0282","article-title":"A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies","volume":"185","author":"Treiber","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabet.2022.101409_bib0009","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/cells9030765","article-title":"Looking at new unexpected disease targets in LMNA-linked lipodystrophies in the light of complex cardiovascular phenotypes: implications for clinical practice","volume":"9","author":"Mosbah","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.diabet.2022.101409_bib0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11892-015-0578-5","article-title":"Lipodystrophic Diabetes Mellitus: a Lesson for other forms of diabetes?","volume":"15","author":"Ficarella","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.diabet.2022.101409_bib0011","doi-asserted-by":"crossref","DOI":"10.2337\/dc21-1395","article-title":"Type 2 diabetes partitioned polygenic scores associate with disease outcomes in 454,193 individuals across 13 cohorts","author":"DiCorpo","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2022.101409_bib0012","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabet.2022.101409_bib0013","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.2337\/db14-0318","article-title":"Genetic evidence for a normal-weight \u201cmetabolically obese\u201d phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes","volume":"63","author":"Yaghootkar","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2022.101409_bib0014","doi-asserted-by":"crossref","first-page":"E856","DOI":"10.1210\/jc.2010-2234","article-title":"A homozygous mutation of prelamin-a preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A","volume":"96","author":"Le Dour","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2022.101409_bib0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ahj.2014.12.021","article-title":"Metabolic and cardiac phenotype characterization in 37 atypical Dunnigan patients with nonfarnesylated mutated prelamin A","volume":"169","author":"Andre","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.diabet.2022.101409_bib0016","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacl.2021.07.004","article-title":"Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2","volume":"15","author":"Lazarte","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.diabet.2022.101409_bib0017","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2337\/diacare.26.5.1350","article-title":"Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety","volume":"26","author":"Haque","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2022.101409_bib0018","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/EJE-20-1013","article-title":"LIPE-related lipodystrophic syndrome: clinical features and disease modeling using adipose stem cells","volume":"184","author":"Sollier","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabet.2022.101409_bib0019","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13023-022-02308-7","article-title":"Dunnigan lipodystrophy syndrome: French national diagnosis and care protocol (PNDS; Protocole National de Diagnostic et de Soins)","volume":"17","author":"Mosbah","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.diabet.2022.101409_bib0020","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2214\/AJR.07.4016","article-title":"Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis","volume":"192","author":"Webb","year":"2009","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.diabet.2022.101409_bib0021","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1464-5491.2002.00745.x","article-title":"The assessment of insulin resistance in man","volume":"19","author":"Wallace","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2022.101409_bib0022","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2022.101409_bib0023","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/dc08-1478","article-title":"Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels","volume":"32","author":"Utzschneider","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2022.101409_bib0024","first-page":"13984","article-title":"Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2","author":"Resende","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.diabet.2022.101409_bib0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-2003-38388","article-title":"Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A\/C R482W mutation","volume":"35","author":"Ara\u00fajo-Vilar","year":"2003","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.diabet.2022.101409_bib0026","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1111\/jocn.14342","article-title":"We're stuck with what we've got\u201d: the impact of lipodystrophy on body image","volume":"27","author":"Adams","year":"2018","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.diabet.2022.101409_bib0027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13023-019-1141-2","article-title":"Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes","volume":"14","author":"Vatier","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.diabet.2022.101409_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002654","article-title":"Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis","volume":"15","author":"Udler","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.diabet.2022.101409_bib0029","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.diabet.2019.12.006","article-title":"Is the type 2 diabetes epidemic plateauing in France? A nationwide population-based study","volume":"46","author":"Fuentes","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2022.101409_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/biom8030047","article-title":"Genetics of lipodystrophy: can it help in understanding the pathophysiology of metabolic syndrome?","volume":"8","author":"Mathur","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.diabet.2022.101409_bib0031","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/21623945.2020.1776082","article-title":"The common pathophysiologic threads between Asian Indian diabetic's \u2018Thin Fat Phenotype\u2019 and partial lipodystrophy: the peripheral adipose tissue transcriptomic evidences","volume":"9","author":"Saxena","year":"2020","journal-title":"Adipocyte"},{"key":"10.1016\/j.diabet.2022.101409_bib0032","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/cen.13732","article-title":"Renal complications of lipodystrophy: a closer look at the natural history of kidney disease","volume":"89","author":"Akinci","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.diabet.2022.101409_bib0033","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/ije\/dyx022","article-title":"Obesity-induced hypoadiponectinaemia: the opposite influences of central and peripheral fat compartments","volume":"46","author":"Borges","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.diabet.2022.101409_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.803189","article-title":"Molecular and cellular bases of lipodystrophy syndromes","volume":"12","author":"Zammouri","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabet.2022.101409_bib0035","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s00125-005-0038-x","article-title":"Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A\/C","volume":"48","author":"Wong","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2022.101409_bib0036","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1210\/jc.2009-1824","article-title":"Higher Adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to Seipin as compared with 1-Acylglycerol-3-Phosphate- O -Acyltransferase-2 Deficiency","volume":"95","author":"Antuna-Puente","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2022.101409_bib0037","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.2337\/db21-0131","article-title":"Low plasma adiponectin in risk of type 2 diabetes: observational analysis and one- and two-sample Mendelian randomization analyses in 756,219 individuals","volume":"70","author":"Nielsen","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2022.101409_bib0038","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363622000908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363622000908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:58:54Z","timestamp":1761130734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363622000908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1262363622000908"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2022.101409","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2022.101409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101409"}}